Skip to main content

SCHRODER INVESTMENT MANAGEMENT GROUP

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1086619 London, X0

Position in SRPT

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$2,241,388
-$2,816,263 QoQ
Shares Held
103,005
-56.2% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SRPT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $603,082,920 across 77 Biotechnology names. SRPT ranks #55 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SRPT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,241,388 103,005
2025-12-31 $5,057,651 235,021
2025-06-30 $884,138 51,704
2025-03-31 $3,851,600 60,351
2024-12-31 $671,540 5,523
2024-09-30 $400,022 3,203
2024-06-30 $5,887,238 37,261
2024-03-31 $2,224,899 17,186
2023-12-31 $2,574,681 26,700
2021-03-31 $134,675 1,807
2020-12-31 $308,075 1,807
2020-09-30 $84,679 603
2020-06-30 $96,685 603
2020-03-31 $36,583 374